AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 15th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • North Carolina
This AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective , 2018 (the “Effective Date”), by and between Robert Lippe (“Executive”) and Liquidia Technologies, Inc., a Delaware corporation (the “Company”). Each of the Company and Executive is a “Party” and, collectively, they are the “Parties.”
EXECUTIVE EMPLOYMENT AGREEMENTSeverance Agreement and General Release • March 15th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • North Carolina
This EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on January 22, 2018, by and between Kevin Gordon (the “Executive”) and Liquidia Technologies, Inc., a Delaware corporation (the “Company”). Each of the Company and Executive is a “Party” and, collectively, they are the “Parties.”
LIQUIDIA TECHNOLOGIES, INC. SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT February 2, 2018Investors’ Rights Agreement • March 15th, 2018 • Liquidia Technologies Inc • Surgical & medical instruments & apparatus • Delaware
This SEVENTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of February 2, 2018 (the “Effective Date”), by and among Liquidia Technology, Inc., a Delaware corporation (the “Company”), the investors listed on Schedule A hereto (each of which is herein referred to as an “Investor”), and the holders of the Company’s Class A Voting Common Stock, $0.001 par value per share (the “Class A Common Stock”) and/or the Company’s Class B Nonvoting Common Stock, $0.001 par value per share (the “Class B Common Stock” and, together with the Class A Common Stock, the “Common Stock”) listed on Schedule B hereto (each of which is herein referred to as a “Common Holder”).
